Abnormal placental invasion-a novel approach to treatment: Case report and review

Obstetrical and Gynecological Survey

Volumn 64, Issue 12, 2009, Pages 811-822

  Ophir, Ella ^a,b   Singer Jordan, Jonathan ^a,b   Odeh, Marwan ^a   Hirch, Yael ^a,b   Maksimovsky, Olga ^a,b   Shaider, Oleg ^a   Yvry, Simon ^a   Solt, Ido ^a   Bornstein, Jacob ^a  

^a WESTERN GALILEE HOSPITAL   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ABNORMAL PLACENTA INVASION; ADULT; ARTIFICIAL EMBOLISM; BALLOON CATHETER; CASE REPORT; CESAREAN SECTION; DIAGNOSTIC ACCURACY; DOPPLER ECHOGRAPHY; EARLY DIAGNOSIS; FEMALE; HIGH RISK PATIENT; HUMAN; INCIDENCE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSTETRIC HEMORRHAGE; PLACENTA DISORDER; PLACENTA INCRETA; PRENATAL DIAGNOSIS; PREOPERATIVE TREATMENT; REVIEW; RISK FACTOR; TREATMENT PLANNING; UTERUS SURGERY;

ADULT; BALLOON OCCLUSION; CESAREAN SECTION; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; PLACENTA; PLACENTA ACCRETA; PREGNANCY; PRENATAL DIAGNOSIS; ULTRASONOGRAPHY, PRENATAL;

EID: 73449134093     PISSN: 00297828     EISSN: 15339866     Source Type: Journal    
DOI: 10.1097/OGX.0b013e3181c46913     Document Type: Review

References (102)

1. Gielchinsky Y, Rojansky W, Fasouliotis SJ, et al. Placenta accreta: summary of 10 years: a survey of 310 cases. Placenta 2002;23:210-214.
2. Cox SM, Carpenter PJ, Cotton DB. Placenta percreta: ultrasound diagnosis and conservative surgical management. Obstet Gynecol 1988;71:454-456.
3. Morison JE. Placenta accreta: a clinicopathologic review of 67 cases. Obstet Gynecol Annu 1978;7:107-123.
4. Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation: twenty-year analysis. Am J Obstet Gynecol 2005;192:1458-1461.
5. Silver RM, Landon MB, Rouse DJ, et al. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol 2006;107:1226-1232.
6. Twickler DM, Lucas MJ, Balis AB, et al. Color flow mapping for myometrial invasion in women with a prior cesarean delivery. J Matern Fetal Med 2000;49:184-197.
7. Finberg HJ, Williams JW. Placenta accreta: prospective sonographic diagnosis in patients with placenta previa and prior cesarean section. J Ultrasound Med 1992;11:333-343.
8. Stricklang S, Richards WS. Invasion of the trophoblasts. Cell 1992;71:355-357.
9. Miller WG. A clinical and pathology study of placenta ac-creta. J Obstet Gynaecol Br Emp 1959;66:353-364.
10. Pijnenborg R. The human deciduas as a passage-way for trophoblast invasion. Trophoblast Res 1998;11:229-241.
11. Knong TG, Robertson WB. Placenta creta and placenta praevia creta. Placenta 1987;8:399-409.
12. Tseng JJ, Chou MM. Differential expression of growth-, an-giogenesis-and invasion-related factors in the development of placenta accreta. Taiwan J Obstet Gynecol 2006;45:100-106.
13. Genbacev O, Zhou Y, Ludlow JW, et al. Regulation of human placental development by oxygen tension. Science 1997; 277:1669-1672.
14. Tantbirojn P, Crum CD, Parast MM. Pathophysiology of placenta creta: the role of deciduas and extravillous cytotropho-blast. Placenta 2008;29:639-645.
15. Edwin WH, Lay-Kok T, Kanagalingam D, et al. Lessons learnt from two women with morbidly adherent placenta and a review of literature. Ann Acad Med Singapore 2007;36:298-303.
16. Miller DA, Chollet JA, Goodwin TM. Clinical risk factors for placenta previa-placenta accreta. Am J Obstet Gynecol 1997;177:210-214.
17. Naeye RL. Maternal age, obstetric complications, and the outcome of pregnancy. Obstet Gynecol 1983;61:210-216.
18. Gielchinsky Y, Mankuta D, Rojansky W, et al. Perinatal outcome of pregnancies complicated by placenta accrete. Ob-stet Gynecol 2004;104:527-530.
19. Friedman A, DeFazio J, DeCherney A. Severe obstetric complications after aggressive treatment of Asherman syndrome. Obstet Gynecol 1986;67:864-867.
20. Norwitz ER, Stern HU, Grier H, et al. Placenta percreta and uterine rupture associated with prior whole body radiation therapy. Obstet Gynecol 2001;98:929-931.
21. Hoffman MK, Sciscione AC. Placenta accreta and intrauter-ine fetal death in a woman with prior endometrial ablation: a case report. J Reprod Med 2004;49:384-386.
22. Clark SL, Koonings PP, Phelan JP. Placenta previa/accreta and prior cesarean section. Obstet Gynecol 1985;66:89-92.
23. Goshen R, Ariel I, Shuster S, et al. Hyaluronan, CD44 and its variant exons in human trophoblast invasion and placental angiogenesis. Mol Hum Reprod 1996;29:685-691.
24. Knong TY, Healy DL, McCloud DI. Pregnancies complicated by abnormally placenta and sex ratio at birth. BMJ 1991;302: 625-626.
25. James WH. Sex ratios of offspring and the causes of pla-cental pathology. Hum Reprod 1995;10:1403-1406.
26. Zelop C, Nadel A, Frigoletto FD, et al. Placenta accreta/ percreta/increta: a cause of elevated maternal serum alpha-fetoprotein. Obstet Gynecol 1992;80:693-694.
27. Kupferminc MJ, Tamura RK, Wigton TR, et al. Placenta ac-creta is associated with elevated maternal serum alpha-fetoprotein. Obstet Gynecol 1993;82:266-269.
28. Hung TH, Shau WY, Hsiech CC, et al. Risk factors for placenta accreta. Obstet Gynecol 1999;93:545-550.
29. Ophir E. Tendler R, Odeh M, et al. Creatine kinase as a biochemical marker in diagnosis of placenta increta and percreta. Am J Obstet Gynecol 1999;180:1039-1040.
30. Mazouni C, Gozincour G, Juban V, et al. Placenta accrete: a review of current advances in prenatal diagnosis. Placenta 2007;28:599-603.
31. Lo YM, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997;350:485-487.
32. Sekizaua A, Sugito H, Luasaki M, et al. Increased cell-free fetal DNA in plasma of two women with invasive placenta. Clin Chem 2002;48:353-354.
33. Ng EK, Tsui NB, Lau TK, et al. mRNA of placental origin is readily detectable in maternal plasma. Proc Natl Acad Sci USA 2003;100:4748-4753.
34. Masuzaki H, Miuza K, Yoshiura K. Placental mRNA in maternal plasma and its clinical application to the evaluation of placental statue in a pregnant woman with placenta previa-percreta. Clin Chem 2005;51:923-925.
35. Miura K, Miura S, Yamasaki Y, et al. Increased level of cell-free placental mRNA in a subgroup of placenta previa that needs hysterectomy. Prenat Diagn 2008;28:805-809.
36. Bilban M, Head S, Desoye G, et al. DNA microassays: a novel approach to investigate genomics in trophoblast invasion-a review. Placenta 2000;21(suppl) 14,S99-S105.
37. Baughman WC, Cozteville JE, Raji RS. Placenta accreta: spectrum of US and MR Imaging findings. Radiographics 2008;28:1905-1916.
38. Warshak CR, Eskander R, Hull AD, et al. Accuracy of ultra-sonography and magnetic resonance imaging in the diagnosis of placenta accreta. Obstet Gynecol 2006;108:573-581.
39. Palacios-Jaraquemada JM. Diagnosis and management of placenta accrete: best practice and research. Clin Obstet Gynaecol 2008;22:1133-1148.
40. Oyelese Y, Smulian JC. Placenta previa, placenta accreta, and vasa previa. Obstet Gynecol 2006;107:927-941.
41. Comstock CH. Antenatal diagnosis of placenta accreta: a review. Ultrasound Obstet Gynecol 2005;26:89-96.
42. Comstock CH, Lee W, Vettraino IM, et al. The early sono-graphic appearance of placenta accreta. J Ultrasound Med 2003;22:19-23.
43. Comstock CH, Love JJ Jr, Bronsteen RA, et al. Sonographic detection of placenta accreta in the second and third trimesters of pregnancy. Am J Obstet Gynecol 2004;190:1135-1140.
44. Yang JI, Lim JK, Kim HS, et al. Sonographic findings of placental lacunae and the prediction of adherent placenta in women with placenta previa totalis and prior cesarean section. Ultrasound Obstet Gynecol 2006;28:178-182.
45. Japaraj RP, Mimin TS, Mukudan K. Antenatal diagnosis of placenta previa accreta in patients with previous cesarean scar. J Obstet Gynecol Res 2007;33:431-437.
46. Chaoui R, Heling KS. Three-dimensional ultrasound in prenatal diagnosis. Curr Opin Obstet Gynecol 2006;18:192-202.
47. Hull AD, Salerno CC, Saenz CC, et al. Three-dimensional ultrasound and diagnosis of placenta percreta with bladder involvement. J Ultrasound Med 1999;18:853-856.
48. Masselli G, Brunelli R, Casciani E, et al. Magnetic resonance imaging in the evaluation of placental adhesive disorders: correlation with color Doppler ultrasound. Eur Radiol 2008; 18:1292-1296.
49. Lerner JP, Deane S, Timor-Tritsh IE. Characterization of placenta accreta using transvaginal sonography and color Doppler imaging. Ultrasound Obstet Gynecol 1995;5:198-201.
50. Chou MM, Ho ES, Lee YH. Prenatal diagnosis of placenta previa accreta by transabdominal color Doppler ultrasound. Ultrasound Obstet Gynecol 2000;15:28-35.
51. Chou MM, Ho ES, Lee YH. Prenatal diagnosis of placenta praevia accreta with colour Doppler, ultrasound. Ultrasound Obstet and Gynecol 1992;1:293-1196
52. Chou MM, Tseng JJ, Ho ES, et al. Three dimensional colour power Doppler imaging in the assessment of uteroplacental neovascularization in placenta praevia increta/percreta. Am J Obstet Gynecol 2001;185:1257-1260.
53. Hudon L, Belfort AM, Broome DR. Diagnosis and management of placenta praevia: a review. Obstet Gynecol Surv 1998;53:509-517.
54. Levine D, Hulka CA, Ludmir J, et al. Placenta accreta: evaluation with color Doppler US, power Doppler US, and MR imaging. Radiology 1997;205:773-776.
55. Shih JC, Palacios Jaraquemada JM, Su YN, et al. Role of three-dimensional power Doppler in the antenatal diagnosis of placenta accreta: comparison with gray-scale and color Doppler techniques. Ultrasound Obstet Gynecol 2009;33: 193-203.
56. Lam G, Kuller J, McMahon M. Use of magnetic resonance imaging and ultrasound in the antenatal diagnosis of placenta accreta. J Soc Gynecol Investig 2002;9:37-40.
57. Lax A, Prince MR, Mennitt KU, et al. The value of specific MRI features in the evaluation of suspected placental invasion. Magn Reson Imaging 2007;25:87-93.
58. Kanal E, Barkovich AY, Bell C, et al. ACR guidance document for safe MR practices: 2007. Am J Roentgenol 2007; 188:1447-1474.
59. Clements H, Duncan KR, Fielding K, et al. Infants exposed to MRI in utero have a normal paediatric assessment at 9 months of age. Br J Radiol 2000;73:190-199.
60. Kok RD, de Vries MM, Heezschan A, et al. Absence of harmful effects of magnetic resonance exposure at 1.5 T in utero during the third trimester of pregnancy: a follow-up study. Magn Reson Imaging 2004;22:851-854.
61. Chen MM, Coakley FV, Kaimal A, et al. Guidelines for computed tomography and magnetic resonance imaging use during pregnancy and lactation. Obstet Gynecol 2008;112: 333-340.
62. Fox H. Placenta accreta 1845-1969. Obstet Gynecol Surv 1972;27:475-479.
63. Tjalma WA, Jacquemyn Y. Letters to the editor-correspondence: compression sutures instead of emergency peripar-tum hysterectomy. Eur J Obstet Gynaecol Reprod Med 2005;118:258-259.
64. Fngeisen IB, Albrechtsen S, Iversen OE. Peripartum hysterectomy-incidence and maternal morbidity. Acta Obstet Gynecol Scand 2001;80:409-412.
65. Kayem G, Davy C, Goffinet F, et al. Conservative versus extirpative management in cases of placenta accreta. Obstet Gynecol 2004;104:531-536.
66. Weinstein A, Chandra P, Schiavello H, et al. Conservative management of placenta previa percreta in a Jehovah's Witness. Obstet Gynecol 2005;105:1247-1250.
67. Ghani R. Conservative management of placenta accreta. J Obstet Gynaecol 2001;21:535.
68. Buckshee K, Dadhwal V. Medical management of placenta accrete. Int J Gynaecol Obstet 1997;59:47-48.
69. Appiah-Sakyi K, Fatima Z, Anjum ZK. Gonadotropin releasing hormone analogues for the management of placenta accreta: a novel concept. J Obstet Gynaecol 2007;27:527-528.
70. Morgan M, Atalla R. Mifepristone and misoprostol for the management of placenta accrete: a new alternative approach. BJOG 2009;116:1002-1003.
71. Timmermans S, van Hof AC, Duvekot JJ. Conservative management of abnormally invasive placentation. Obstet Gynecol Surv 2007;62:529-539.
72. Bretelle F, Courbiere B, Mazouni C, et al. Management of placenta accreta: morbility and outcome. Eur J Obstet Gynecol Reprod Biol 2007;133:34-39.
73. Nishijima K, Shukunami K, Azikuza S, et al. An operative technique for conservative management of placenta accreta. Obstet Gynecol 2005;105:1201-1203.
74. Tan CH, Tay KH, Sheah K. Perioperative endovascular internal iliac artery occlusion balloon placement in management of placenta accreta. AJR 2007;189:1158-1163.
75. Weeks SM, Stroud TH, Sandhu J, et al. Temporary balloon occlusion of the internal iliac arteries for control of hemorrhage during arteries for control of hemorrhage during ce-sarean hysterectomy in a patient with placenta previa and placenta increta. J Vasc Interv Radiol 2000;11:622-624.
76. Ikeda T, Sameshida H, Kawaguchi H, et al. Tourniquet technique prevents profuse blood loss in placenta accrete cesar-ean section. J Obstet Gynecol Res 2005;31:27-31.
77. Verspyck E, Resch B, Sergent F, et al. Surgical uterine devascularization for placenta accreta: immediate and long-term follow-up. Acta Obstet Gynecol Scand 2005;84:444-447.
78. Paull JD, Smith J, Williams L, et al. Balloon occlusion of the abdominal aorta during cesarean hysterectomy for placenta percreta. Anaesth Intensive Care 1995;23:731-734.
79. DuBois J, Garel L, Grignon A, et al. Placenta percreta: balloon occlusion and embolization of the internal iliac arteries to reduce intraoperative blood losses. Am J Obstet Gynecol 1997;176:723-726.
80. Kidney DD, Nguyen AM, Ahdoot D, et al. Prophylactic peri-operative hypogastric artery balloon occlusion in abnormal placentation. Am J Roentgenol 2001;176:1521-1524.
81. Hong TM, Tseng HS, Lee RC, et al. Uterine artery emboliza-tion: an effective treatment for intractable obstetric haemorrhage. Clin Radiol 2004;59:96-101.
82. Chou MM, Hwang JI, Tseng JJ. Internal iliac artery emboli-zatiojn before hysterectomy for placenta accreta. J Vasc Interv Radiol 2003;14:1195-1199.
83. Shrivastava V, Nageotte M, Major C, et al. Case-control comparison of cesarean hysterectomy with and without prophylactic placement of intravascular balloon catheters for placenta accreta. Am J Obstet Gynecol 2007;197:402.e1-402. e5.
84. Bodner LJ, Nosher JL, Gribbin C, et al. Balloon-assisted occlusion of the internal iliac arteries in patients with placenta accreta/percreta. Cardiovasc Intervent Radiol 2006; 29:354-361.
85. Greenberg JI, Suiliman A, Iranpour P, et al. Prophylactic balloon occlusion of the internal iliac arteries to treat abnormal placentation: a cautionary case. Am J Obstet Gynecol 2007;197:470.e1-470.e4.
86. Ojala K, Perala J, Kariniemi J, et al. Arterial embolization and prophylactic catheterization for treatment for severe obstetric hemorrhage. Acta Obstet Gynecol Scand 2005;84:1075-1080.
87. Mitty HA, Sterling KM, Alvarez M, et al. Obstetric hemorrhage: prophylactic and emergency arterial catheterization and embolotherapy. Radiology 1993;188:183-187.
88. Alanis M, Hurst BS, Marshburn PB, et al. Conservative management of placenta increta with selective arterial emboliza-tion preserves future fertility and results in a favorable outcome in subsequent pregnancies. Fertil Steril 2006;86: 1514.e3-1514.e7.
89. Chou YJ, Cheng YF, Shen CC, et al. Failure of uterine arterial embolization: placenta accreta with profuse postpartum haemorrhage. Acta Obstet Gynecol Scand 2004;83:688-690.
90. Vedantham S, Goodwin SC, McLucas B, et al. Uterine artery embolization: an underused method of controlling pelvic hemorrhage. Am J Obstet Gynecol 1997;176:938-948.
91. Chin HG, Scott DR, Resnik R, et al. Angiographic emboliza-tion of intractable puerperal hematomas. Am J Obstet Gynecol 1989;160:434-438.
92. Gilbert WM, Moore TR, Resnik R, et al. Angiographic embo-lization in the management of hemorrhagic complications of pregnancy. Am J Obstet Gynecol 1992;166:493-497.
93. Hansch E, Chitkara U, McAlpine J, et al. Pelvic arterial em-bolization for control of obstetric hemorrhage; a five year experience. Am J Obstet Gynecol 1999;180:1454-1460.
94. Scarantino SE, Reilly JG, Moretti ML, et al. Argon beam coagulation in the management of placenta accreta. Obstet Gynecol 1999;94(5 pt 2):825-827.
95. Cho J, Kim S, Cha K, et al. Interrupted circular suture: bleeding control during cesarean delivery in placenta previa accreta. Obstet Gynecol 1991;78:876-879.
96. Slomko Z, Kedzia H, Friebe Z. Partial excision of anterior uterine wall for placenta accreta. Ginekol Pol 1994;65:326-330.
97. Holtsema H, Niland R, Nuisman A, et al. The B-Lynch technique for postpartum haemorrhage: an option for every gynaecologist. Eur J Obstet Gynecol 2004;115:39-42.
98. Hayman RG, Arulkumaran S, Steer PJ. Uterine compression suture: surgical management of postpartum hemorrhage. Obstet Gynecol 2002;99:502-506.
99. Hwu YM, Chen CP, Chen HS, et al. Parallel vertical compression sutures: a technique to control bleeding from placenta praevia or accreta during caesarean section. BJOG 2005;112:1420-1423.
100. Daulatly B, Wong I, Khan K, et al. Using the cervix to stop bleeding in a woman with placenta accreta: a case report. BJOG 2007;114:502-504.
101. Bennich G, Langhoff-Ross J. Placenta percreta treated using a new surgical technique. Eur J Obstet Gynecol Reprod Med 2005;122:122-125.
102. Riggs JC, Jahshan A, Schiavello HJ. Alternative conservative management of placenta accrete: a case report. J Reprod Med 2000;45:595-598.